glucagen 1 mg/1 ml pó e solvente para solução injetável
novo nordisk portugal, lda. - glucagom - pó e solvente para solução injetável - 1 mg/1 ml - glucagom, cloridrato 1 mg - glucagon - n/a - duração do tratamento: curta ou média duração
glucagen 1 mg/1 ml pó e solvente para solução injetável
novo nordisk portugal, lda. - glucagom - pó e solvente para solução injetável - 1 mg/1 ml - glucagom, cloridrato 1 mg - glucagon - n/a - duração do tratamento: curta ou média duração
glucagen
novo nordisk farmacÊutica do brasil ltda - glucagon - antidiabeticos
baqsimi
eli lilly nederland b.v. - glucagon - diabetes mellitus - pâncreas hormônios, hormônios glycogenolytic - baqsimi é indicado para o tratamento de hipoglicemia grave em adultos, adolescentes e crianças com idade entre 4 e mais anos com diabetes mellitus.
ogluo
tetris pharma b.v - glucagon - diabetes mellitus - pâncreas hormônios, hormônios glycogenolytic - ogluo is indicated for the treatment of severe hypoglycaemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus.
glucagon
eli lilly do brasil ltda - antidiabeticos
galvus
novartis europharm limited - vildagliptina - diabetes mellitus, tipo 2 - drogas usadas em diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.
jalra
novartis europharm limited - vildagliptina - diabetes mellitus, tipo 2 - dipeptidyl peptidase 4 (dpp-4) inhibitors, drugs used in diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 e 5. 1 para dados disponíveis em diferentes combinações).
xiliarx
novartis europharm limited - vildagliptina - diabetes mellitus, tipo 2 - drogas usadas em diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 e 5. 1 para dados disponíveis em diferentes combinações).
lyxumia
sanofi winthrop industrie - lixisenatida - diabetes mellitus, tipo 2 - drugs used in diabetes, glucagon-like peptide-1 (glp-1) analogues - lyxumia is indicated for the treatment of adults with type 2 diabetes mellitus to achieve glycaemic control in combination with oral glucose lowering medicinal products and/or basal insulin when these, together with diet and exercise, do not provide adequate glycaemic control.